<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00279149</url>
  </required_header>
  <id_info>
    <org_study_id>P 030443</org_study_id>
    <nct_id>NCT00279149</nct_id>
  </id_info>
  <brief_title>TRUST-tPA: Therapeutic Trial Evaluating Efficacy of Telemedicine (TELESTROKE) of Patients With Acute Stroke</brief_title>
  <official_title>Therapeutic Trial Evaluating Efficacy of Telemedicine (TELESTROKE) in the Management of Patient With Acute Stroke Within 3-hour After Their Symptom Onset Who Are Admitted to a Remote Hospital With no Stroke Unit Facility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to evaluate decision making of i.v. tPA treatment in acute stroke within 3&#xD;
      hours of symptom onset either remotely via videoconferencing system (investigational arm)&#xD;
      beginning of treatment on-site and then transfer to stroke unit vs. decision after immediate&#xD;
      transfer to stroke unit (usual care arm). Ten remote hospitals are connected to the BICHAT&#xD;
      stroke unit. All patients will have stroke unit care at BICHAT hospital. Primary end-point is&#xD;
      rankin 0-1 at 3 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a therapeutic trial, comparing a TELESTROKE decision making as the tested&#xD;
      hypothesis to usual care (immediate transfer to stroke unit). Once the ER doctor in one of&#xD;
      the 10 remote hospitals will judge his patient eligible for tPA thrombolysis, he will call&#xD;
      the BICHAT stroke unit visio-conference system. Then, according to the randomization list,&#xD;
      the patient will be allocated to 'standard care arm' which is the EMEA-approved tPA labeling&#xD;
      (i.e., transfer the patient immediately to a stroke unit to have tPA thrombolysis if the&#xD;
      patient arrives in due time -before 3 hours of stroke onset) or he will be allocated to&#xD;
      'TELESTROKE ARM&quot;(i.e., remote neurological exam to perform NIHSS, assess the exact time of&#xD;
      the first stroke symptoms onset and visualization of brain CT-scan by the vascular&#xD;
      neurologist; then start the tPA thrombolysis on site if the indication is confirmed by the&#xD;
      vascular neurologist, then transfer the patient to the BICHAT stroke unit). The primary&#xD;
      outcome will be Rankin 0-1 (i.e., cured) at 3 months; secondary outcome will be death or&#xD;
      dependency at 3 months and the frequency of symptomatic intracranial hemorrhage at 10 days.&#xD;
      Patients randomized will be systematically transfer to the BICHAT stroke unit, no matter the&#xD;
      received or not tPA thrombolysis, and no matter the study arm, according to the&#xD;
      intention-to-treat rule.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients cured at 3 months (rankin score 0,1)</measure>
    <time_frame>at 3 months</time_frame>
    <description>Percentage of patients cured at 3 months (rankin score 0,1)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NIHSS, rankin score ( 0,1,2) and Barthel Index at 3 months ,</measure>
    <time_frame>at 3 months</time_frame>
    <description>NIHSS, rankin score ( 0,1,2) and Barthel Index at 3 months ,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of symptomatic intracranial hemorrhage at 8 days</measure>
    <time_frame>at 8 days</time_frame>
    <description>percentage of symptomatic intracranial hemorrhage at 8 days</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Acute Stroke</condition>
  <arm_group>
    <arm_group_label>surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Visio conference system connected to the Tele-stroke network</intervention_name>
    <description>Visio conference system connected to the Tele-stroke network</description>
    <arm_group_label>surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients older than 18 years&#xD;
&#xD;
          -  symptoms of brain infarction since less than 150 minutes&#xD;
&#xD;
          -  NIHSS between 4 and 22&#xD;
&#xD;
          -  No brain hemorrhage on contrast CT-scan&#xD;
&#xD;
          -  Signed consent form by the patient or his relatives&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  NIHSS above 22 or coma&#xD;
&#xD;
          -  current oral anticoagulant or INR &gt; 1.7&#xD;
&#xD;
          -  heparin treatment within the preceding 24 hours or prolonged APTT (&gt;40seconds)&#xD;
&#xD;
          -  platelets count &lt; 100 000/mm3&#xD;
&#xD;
          -  another stroke or brain trauma within 3 months prior admission&#xD;
&#xD;
          -  systolic blood pressure &gt; 185 or diastolic blood pressure &gt; 110 at the time od tPA&#xD;
             treatment onset&#xD;
&#xD;
          -  neurologic deficit is improving&#xD;
&#xD;
          -  history of intracranial hemorrhage&#xD;
&#xD;
          -  glycemia less than 0.5g/l or upper than 4g/l after treatment by Actrapid&#xD;
&#xD;
          -  epileptic seizure at the time of stroke onset&#xD;
&#xD;
          -  Gastro-intestinal or urinary hemorrhage&#xD;
&#xD;
          -  Recent myocardial infarction within the last 21 days&#xD;
&#xD;
          -  Lumbar puncture or arterial blood sampling in a non compressible vessel within the&#xD;
             last 7 days&#xD;
&#xD;
          -  Hemophilia&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Pericarditis within the last 3 months&#xD;
&#xD;
          -  Major surgery within the last 15 days&#xD;
&#xD;
          -  History of aortic dissection&#xD;
&#xD;
          -  Endocarditis with the last 3 months&#xD;
&#xD;
        Brain CT scan exclusion criteria:&#xD;
&#xD;
          -  Mass effect ( tumor, VAM, aneurism )&#xD;
&#xD;
          -  Decreased density ( ASPECTS score &lt; 8) or mass effect involving more than 1/3 of the&#xD;
             territory of the middle cerebral artery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre AMARENCO, Pr,MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital d'Argenteuil, Emergency Unit</name>
      <address>
        <city>Argenteuil</city>
        <zip>95100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Avicenne, Emergency Unit</name>
      <address>
        <city>Bobigny</city>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Ambroise Paré, Emergency Unit</name>
      <address>
        <city>Boulogne</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Beaujon, Emergency Unit</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis Mourier, Emergency Unit</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de Compiègne, Emergency Unit</name>
      <address>
        <city>Compiegne</city>
        <zip>60200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de Lagny sur Marne, Emergency Unit</name>
      <address>
        <city>Lagny</city>
        <zip>77400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BICHAT HOSPITAL Departement of Neurology</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de Provins, Emergency Unit</name>
      <address>
        <city>Provins</city>
        <zip>77160</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <study_first_submitted>January 13, 2006</study_first_submitted>
  <study_first_submitted_qc>January 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2006</study_first_posted>
  <last_update_submitted>February 16, 2011</last_update_submitted>
  <last_update_submitted_qc>February 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Zakia Idir</name_title>
    <organization>Department Clinical Research of Developpement</organization>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>TELESTROKE</keyword>
  <keyword>symptoms of ischemic stroke since less than 3 hours</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

